Smart earbuds that listen to your heart could lull you to sleep
NCT ID NCT07744581
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This trial tests a pair of smart earbuds that use artificial intelligence to adjust soothing music in real time based on your heart rate and movement, aiming to help people with chronic insomnia fall asleep faster and sleep deeper. Adults with chronic insomnia will spend three nights in a sleep lab, trying both the AI-adaptive music and standard non-adaptive music, while researchers compare the earbuds' built-in sensors against clinical sleep monitoring equipment. After the lab phase, participants use the earbuds at home for two weeks. The goal is to see if personalized sound therapy can ease insomnia and if a consumer earbud can track sleep as accurately as a hospital system.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- AI-driven neuromodulation music delivered via smart earbuds (NeuroRhythm)
- What this could lead to
- If effective, this could offer a drug-free, personalized way to treat chronic insomnia and validate consumer earbuds as accurate sleep trackers.
- What could go wrong
- This is a small early-stage trial (25 people) and results may not apply to everyone. The device's accuracy and effectiveness compared to standard music are still unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 25 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2026
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria * Aged 18 to 55 years (inclusive). * Able to understand the study protocol and voluntarily sign the informed consent form. * Meets the diagnostic criteria for chronic insomnia disorder according to the International Classification of Sleep Disorders, Third Edition (ICSD-3) or DSM-5. * Duration of insomnia symptoms is greater than 3 months but less than 2 years. * Insomnia Severity Index (ISI) total score \> 8 (indicating mild or greater clinical insomnia). * Currently drug-free status: No use of any prescription or over-the-counter medications that affect sleep (including sedatives, hypnotics, antidepressants, antihistamines, or traditional Chinese medicine sleep aids) for at least 2 weeks (or more than 5 drug half-lives) prior to enrollment. * Owns a smartphone and is capable of operating mobile applications to complete electronic questionnaires. * Willing and able to tolerate wearing earplugs or earbuds during sleep. Exclusion Criteria * Comorbid primary sleep disorders: Diagnosed via screening (STOP-Bang questionnaire) or polysomnography (PSG) with moderate-to-severe obstructive sleep apnea (OSA, defined as Apnea-Hypopnea Index $\\ge$ 15), narcolepsy, periodic limb movement disorder (PLMD), or other sleep disorders that could interfere with sleep quality assessments. * Severe psychiatric or psychological conditions: A Patient Health Questionnaire (PHQ-9) score \> 10 or a Generalized Anxiety Disorder scale (GAD-7) score \> 10. * History of schizophrenia, bipolar disorder, major depressive disorder, or active suicidal ideation. * Active substance abuse or dependence: History of alcohol abuse (exceeding 14 standard drinks per week) or illicit drug use within the past 3 months. * Comorbid somatic medical conditions: Severe or unstable physical illnesses (e.g., severe heart failure, malignant tumors, chronic pain) or neurological disorders known to impair sleep monitoring accuracy. * Active ear diseases, ear canal discharge, structural abnormalities, or a history of related otologic surgeries that prevent or restrict earbud placement. * Known history of hypersensitivity or allergic reactions to silicone or plastic materials. * Disruptive lifestyle factors: Current engagement in shift work schedules or travel across more than 3 time zones within 2 weeks prior to study entry. * Inability to provide independent informed consent or successfully complete cognitive testing due to profound language or cognitive barriers.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Insomnia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Longgang Ear, Nose and Throat Hospital
Shenzhen, Guangdong, 518100, China
-
The Chinese University of Hong Kong Shenzhen
Shenzhen, Guangdong, 518172, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can magnetic brain zaps ease the pain of a sleepless body?
- Can poor sleep make you hurt more? study probes Insomnia's link to pain
- Does soreness after exercise disrupt sleep more for people with insomnia?
- Can fixing insomnia help heavy drinkers cut back?
- Can a sleep therapy program help control blood sugar in older diabetes patients?
- Can better sleep cut heavy drinking? therapy tested in veterans